Ventricular Tachycardia Clinical Trial
Official title:
Effect of Amiodarone After Ischemic Ventricular Tachycardia Ablation
Ventricular Tachycardia ablation in ischemic cardiomyopathy patients is required procedure in cases when anti-arrhythmic drugs failed. The concern is if adjunctive continuation amiodarone after ablation is needed.
Ischemic cardiomyopathy patients have implantable cardioverter defibrillators (ICD) to
prevent arrhythmic deaths. Ventricular tachycardia (VT) events with frequent ICD
interventions in ischemic cardiomyopathy patients is encountered frequently. Frequents ICD
interventions is associated with worse outcomes. Anti-arrhythmic drugs ,mostly amiodarone,
are given prevent ventricular arrhythmias and ICD interventions that may not be curative.
Ablation of ventricular tachycardia is the suggested treatment when anti-drugs are without
effect. After ablation of ventricular arrhythmia the continuation of amiodarone is not well
elucidated.
In this study we aimed to enroll ischemic cardiomyopathy patients having frequent ICD
interventions despite medical treatment. VT ablation is performed and patients divided into
two groups; group one continues having amiodarone after ablation, group two does not have
amiodarone after ablation. Both groups will be compared in terms of recurrence and death.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03453645 -
Modification of Rhythmic Risk Assessment by Ventricular Tachycardia Ablation
|
||
Completed |
NCT05791032 -
Sub Chronic Evaluation for ATP With an Extravascular Placed ICD Lead (STEP ICD) Study
|
N/A | |
Completed |
NCT05970120 -
A Study of Intracardiac Ultrasound With the NUVISION NAV Ultrasound Catheter
|
N/A | |
Completed |
NCT04011631 -
Evaluation of the iD-SystemTM, One-Handed Disposable Internal Defibrillation System.
|
N/A | |
Recruiting |
NCT03536052 -
Ablation at Virtual-hEart pRedicted Targets for VT
|
N/A | |
Not yet recruiting |
NCT06063811 -
Ventricular Tachycardia Ablation in LVAD Patients
|
||
Enrolling by invitation |
NCT02962076 -
Study of Cardiac PET/CT Imaging to Guide Ablation Treatment of Ventricular Tachycardia
|
Early Phase 1 | |
Not yet recruiting |
NCT02784912 -
Biomarkers in Risk Stratification of Sustainted Ventricular Tachycardia or Electrical Storm After Ablation
|
N/A | |
Completed |
NCT01791543 -
Intramural Needle Ablation for Ablation of Recurrent Ventricular Tachycardia
|
N/A | |
Terminated |
NCT02891863 -
Low Energy Therapy to Convert Ventricular Tachycardias
|
Phase 0 | |
Terminated |
NCT01546207 -
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
|
N/A | |
Completed |
NCT01294267 -
Percutaneous Hemodynamic Support With Impella 2.5 During Scar-related Ventricular Tachycardia Ablation
|
N/A | |
Terminated |
NCT00383799 -
Iv Amiodarone Versus Iv Procainamide to Treat Haemodynamically Well Tolerated Ventricular Tachycardia
|
Phase 4 | |
Completed |
NCT04884100 -
enHEART - Exploring Full Content of Optical Signals to Enhance Cardiac Arrhythmia Screening
|
N/A | |
Completed |
NCT04642963 -
Stereotactic Management of Arrhythmia - Radiosurgery in Treatment of Ventricular Tachycardia
|
N/A | |
Recruiting |
NCT05377216 -
Characterization of Cardiac Electrophysiological Effects of Autonomic Neuromodulation
|
Early Phase 1 | |
Not yet recruiting |
NCT04990089 -
VIVO European Observational Registry
|
||
Completed |
NCT04065893 -
Impact of Catheter Ablation of Ventricular Arrhythmias on Suboptimal Biventricular Pacing in Cardiac Resynchronization Therapy
|
||
Recruiting |
NCT03631303 -
Post-Extrasystolic Potentiation as a Predictor of Ventricular Arrhythmias
|
||
Recruiting |
NCT03611465 -
Creation of a Pace-mapping Atlas on Healthy and Pathological Hearts
|
N/A |